clinical trial · NCT02853136
Influence of Fluvoxamine on the Pharmacokinetics of BI 409306
Boehringer Ingelheim·phase1·completed·n = 18
HealthyFluvoxamineBI 409306 - Powder for oral solution (PfOS)BI 409306 - film coated tablet
brief summary
To investigate the influence of fluvoxamine on the pharmacokinetics of BI 409306
started
Aug 25, 2016
primary completion
Oct 17, 2016
completion
Oct 25, 2016
last updated
Aug 21, 2024
official title
Influence of Fluvoxamine on the Pharmacokinetics of BI 409306 After Oral Administration (Randomized, Open-label, Two-treatment, Two-sequence, Two-period Crossover Study)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol